Biogenesis_AI

Proprietary Research Engine v2.0

🧬 BioGenesis AI

Bridging Generative Intelligence and Pharmacological Precision

Welcome to BioGenesis AI, a premier de novo drug design platform developed by Sarweshwar Intellectuals. Our system navigates the astronomical complexity of chemical space using high-dimensional protein language models and reinforcement learning to deliver tailored lead molecules.

Conditional Generation

Novel structures generated based on specific amino acid sequences (ESM-2 650M architecture).

Affinity Prediction

Integrated regression models providing pIC50 estimates for every generated candidate.

Specificity Audited

Causal metrics ensure chemical functional groups are tailored to the unique binding pocket of your target.

The BioGenesis Pipeline

1
Target Input: Input your FASTA protein sequence for deep biological fingerprinting.
2
Autonomous Design: AI creates entities filtered for Lipinski’s Rule of Five and SA Score.
3
Lead Optimization: Fine-tuning via Reinforcement Learning to maximize QED and binding affinity.
4
IPR Ready: Comprehensive reports designed to support Patent Filings and FER responses.

“Our mission is to democratize drug discovery, enabling every researcher to harness the power of an A100-backed AI laboratory from their browser.”

— Dr. Swayamprakash Patel
| Associate Professor, RPCP (CHARUSAT)

🚀 Access BioGenesis Tool